VERACYTE, INC.
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Mailing Address 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Phone (650) 243-6300
Fiscal Year End 1231
EIN 205455398
Financial Overview
FY2024
-$36.56M
Net Income
$1.30B
Total Assets
$239.09M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 3, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | December 17, 2025 | View on SEC |
| 4 Insider stock transaction report | December 8, 2025 | View on SEC |
| 4 Insider stock transaction report | December 4, 2025 | View on SEC |
| 4 Insider stock transaction report | December 4, 2025 | View on SEC |
| 4 Insider stock transaction report | December 4, 2025 | View on SEC |
| 4 Insider stock transaction report | December 4, 2025 | View on SEC |
Insider Trading
STRONG SELL 7 insiders
17 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.